{"address1": "68 TW Alexander Drive", "address2": "PO Box 13628", "city": "Research Triangle Park", "state": "NC", "zip": "27709", "country": "United States", "phone": "919 636 4530", "website": "https://www.fennecpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.", "fullTimeEmployees": 32, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert C. Andrade", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 864783, "exercisedValue": 0, "unexercisedValue": 4011361}, {"maxAge": 1, "name": "Mr. Jeffrey S. Hackman", "age": 61, "title": "CEO & Director", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Terry  Evans", "title": "Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pierre S. Sayad M.S., Ph.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Christiana  Cioffi M.B.A.", "title": "Chief Strategy Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Gowland", "title": "Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Lei  Fang", "title": "President of Pharstat Inc", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 5, "compensationRisk": 8, "shareHolderRightsRisk": 5, "overallRisk": 6, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.21, "open": 8.05, "dayLow": 8.05, "dayHigh": 8.48, "regularMarketPreviousClose": 9.21, "regularMarketOpen": 8.05, "regularMarketDayLow": 8.05, "regularMarketDayHigh": 8.48, "payoutRatio": 0.0, "beta": 0.357, "volume": 588, "regularMarketVolume": 588, "averageVolume": 980, "averageVolume10days": 650, "averageDailyVolume10Day": 650, "bid": 8.4, "ask": 8.72, "bidSize": 0, "askSize": 0, "marketCap": 233997104, "fiftyTwoWeekLow": 5.65, "fiftyTwoWeekHigh": 15.0, "priceToSalesTrailing12Months": 4.922317, "fiftyDayAverage": 9.381, "twoHundredDayAverage": 8.10525, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "CAD", "tradeable": false, "enterpriseValue": 246846816, "forwardPE": 8.151887, "profitMargins": -0.0091699995, "floatShares": 14397726, "sharesOutstanding": 27594000, "sharesShort": 23594, "sharesShortPriorMonth": 23594, "sharesShortPreviousMonthDate": 1739836800, "dateShortInterest": 1742169600, "sharesPercentSharesOut": 0.00090000004, "heldPercentInsiders": 0.16166, "heldPercentInstitutions": 0.58474, "shortRatio": 38.49, "shortPercentOfFloat": 0.0013, "impliedSharesOutstanding": 27594000, "bookValue": -0.213, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -436000, "trailingEps": -0.03, "lastSplitFactor": "1:3", "lastSplitDate": 1409875200, "enterpriseToRevenue": 5.193, "enterpriseToEbitda": 68.569, "52WeekChange": -0.4346667, "SandP52WeekChange": 0.101756096, "quoteType": "EQUITY", "currentPrice": 8.48, "recommendationKey": "none", "totalCash": 26634000, "totalCashPerShare": 0.965, "ebitda": 3600000, "totalDebt": 19340000, "quickRatio": 5.712, "currentRatio": 6.377, "totalRevenue": 47538000, "revenuePerShare": 1.742, "returnOnAssets": 0.044699997, "grossProfits": 44354000, "freeCashflow": -289750, "operatingCashflow": 26980000, "revenueGrowth": -0.186, "grossMargins": 0.93302, "ebitdaMargins": 0.075729996, "operatingMargins": -0.11785, "financialCurrency": "USD", "symbol": "FRX.TO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1743623982, "exchange": "TOR", "messageBoardId": "finmb_1455350", "exchangeTimezoneName": "America/Toronto", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "ca_market", "esgPopulated": false, "regularMarketChangePercent": -7.9261727, "regularMarketPrice": 8.48, "shortName": "FENNEC PHARMACEUTICALS INC", "longName": "Fennec Pharmaceuticals Inc.", "marketState": "PREPRE", "regularMarketDayRange": "8.05 - 8.48", "fullExchangeName": "Toronto", "averageDailyVolume3Month": 980, "fiftyTwoWeekLowChange": 2.8299994, "fiftyTwoWeekLowChangePercent": 0.50088483, "fiftyTwoWeekRange": "5.65 - 15.0", "fiftyTwoWeekHighChange": -6.5200005, "fiftyTwoWeekHighChangePercent": -0.4346667, "fiftyTwoWeekChangePercent": -43.46667, "earningsTimestamp": 1741600980, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747657800, "earningsCallTimestampStart": 1741609800, "earningsCallTimestampEnd": 1741609800, "isEarningsDateEstimate": true, "priceEpsCurrentYear": -107.00315, "fiftyDayAverageChange": -0.901, "fiftyDayAverageChangePercent": -0.0960452, "twoHundredDayAverageChange": 0.37474918, "twoHundredDayAverageChangePercent": 0.04623536, "priceToBook": -39.812206, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "cryptoTradeable": false, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 992352600000, "regularMarketChange": -0.7300005, "epsTrailingTwelveMonths": -0.03, "epsCurrentYear": -0.07925, "trailingPegRatio": null}